Water vapor thermal therapy: Technical variations among spanish hospitals and efficacy at 2-year follow-up

Actas Urológicas Españolas (English Edition) - Tập 47 - Trang 668-674 - 2023
I. Schwartzmann1, S. García Barreras2, M. D’Anna3, V. Parejo4, I. Torneo Ruiz5, A.C. Tagalos Muñoz2, A. Bravo-Balado1, P. Diana1, L. Peri3, M. Domínguez Esteban6, E. Fernández Guzmán6
1Servicio de Urología de la Fundació Puigvert, Barcelona, Spain
2Servicio de Urología, Hospital Ramon y Cajal, Madrid, Spain
3Servicio de Urología, Hospital Clínic, Barcelona, Spain
4Servicio de Urología, Hospital de Girona Dr. Josep Trueta, Gerona, Spain
5Servicio de Urología, Hospital Virgen de la Arrixaca, Murcia, Spain
6Servicio de Urología, Hospital Universitario Marqués de Valdecillas, Santander, Spain

Tài liệu tham khảo

Dmochowski, 2005, Bladder outlet obstruction: etiology and evaluation, Rev Urol., 7, S3 Castro-Díaz, 2013, [Benign prostatic hyperplasia and its treatment: impact on quality of life and sexual function], Actas Urol Esp., 37, 233, 10.1016/j.acuro.2012.08.001 Carrero-López, 2016, Benign prostatic hyperplasia and lower urinary tract symptoms. A review of current evidence, Actas Urol Esp., 40, 288, 10.1016/j.acuro.2015.12.008 Dixon, 2015, Transurethral convective water vapor as a treatment for lower urinary tract symptomatology due to benign prostatic hyperplasia using the Rezūm(®) system: evaluation of acute ablative capabilities in the human prostate, Res Rep Urol., 7, 13 McVary, 2019, Rezūm water vapor thermal therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia: 4-year results from randomized controlled study, Urology., 126, 171, 10.1016/j.urology.2018.12.041 Gupta, 2018, Three-year treatment outcomes of water vapor thermal therapy compared to doxazosin, finasteride and combination drug therapy in men with benign prostatic hyperplasia: cohort data from the MTOPS trial, J Urol., 200, 405, 10.1016/j.juro.2018.02.3088 McVary, 2018, Is sexual function better preserved after water vapor thermal therapy or medical therapy for lower urinary tract symptoms due to benign prostatic hyperplasia?, J Sex Med., 15, 1728, 10.1016/j.jsxm.2018.10.006 McVary, 2021, Final 5-year outcomes of the multicenter randomized sham-controlled trial of a water vapor thermal therapy for treatment of moderate to severe lower urinary tract symptoms secondary to benign prostatic hyperplasia, J Urol., 206, 715, 10.1097/JU.0000000000001778 Fernández-Guzmán, 2022, Resultados preliminares de un trabajo multicéntrico a nivel nacional para el tratamiento de STUI secundario a hiperplasia benigna de próstata mediante el sistema con vapor de agua Rezūm®, Actas Urol Esp., 46, 310, 10.1016/j.acuro.2021.11.003 Rukstalis, 2019, Prostatic Urethral Lift (PUL) for obstructive median lobes: 12 month results of the MedLift Study, Prostate Cancer Prostatic Dis., 22, 411, 10.1038/s41391-018-0118-x Mollengarden, 2018, Convective radiofrequency water vapor thermal therapy for benign prostatic hyperplasia: a single office experience, Prostate Cancer Prostatic Dis., 21, 379, 10.1038/s41391-017-0022-9 Alegorides, 2020, Treatment of benign prostate hyperplasia using the Rezum® water vapor therapy system: Results at one year, Prog Urol., 30, 624, 10.1016/j.purol.2020.05.004 Darson, 2017, Procedural techniques and multicenter postmarket experience using minimally invasive convective radiofrequency thermal therapy with Rezūm system for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia, Res Rep Urol., 9, 159